Skip to main content

JPMORGAN CHASE & CO

Position in SRPT — Sarepta Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in SRPT

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$15,301,433
-$709,186 QoQ
Shares Held
703,191
-5.5% QoQ
Ownership
0.666%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 92.19088412678774.ToString("F0")% Shared 0.ToString("F0")% None 7.8091158732122565.ToString("F0")%

Common Shares in SRPT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. SRPT ranks #63 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SRPT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $15,301,433 703,191
2025-12-31 $16,010,619 743,988
2025-09-30 $12,898,989 669,382
2025-06-30 $11,152,598 652,199
2025-03-31 $143,239,645 2,244,432
2024-12-31 $245,685,236 2,020,604
2024-09-30 $274,618,492 2,198,883
2024-06-30 $291,315,502 1,843,769
2024-03-31 $236,730,808 1,828,602
2023-12-31 $125,605,566 1,302,557
2023-09-30 $558,619,941 4,608,315
2023-06-30 $504,356,725 4,404,093
2023-03-31 $510,376,765 3,702,944
2022-12-31 $161,125,858 1,243,447
2022-09-30 $79,700,773 721,013
2022-06-30 $76,740,145 1,023,748
2022-03-31 $85,202,824 1,090,666
2021-12-31 $94,428,498 1,048,623
2021-09-30 $139,959,504 1,513,403
2021-06-30 $101,555,023 1,306,342
2021-03-31 $56,165,654 753,598
2020-12-31 $128,651,580 754,599
2020-09-30 $158,195,654 1,126,509
2020-06-30 $253,002,565 1,577,913
2020-03-31 $111,951,367 1,144,463